首页> 外文期刊>Patient Related Outcome Measures >Longitudinal analysis of quality of life in patients with undifferentiated connective tissue diseases
【24h】

Longitudinal analysis of quality of life in patients with undifferentiated connective tissue diseases

机译:未分化结缔组织病患者生活质量的纵向分析

获取原文
       

摘要

Introduction/objectives: To prospectively assess the quality of life (QoL) of patients affected by undifferentiated connective tissue diseases (UCTDs) and to identify factors associated with changes over time. Patients and methods: A total of 46 consecutive UCTD patients completed the Short-Form 36 (SF-36) questionnaire at presentation and then yearly. At each 6-month visit, all patients underwent a detailed history taking and a laboratory and physical assessment, in order to follow the evolution of the disease over time and to assess the the co-existence of fibromyalgia. Results: At presentation, scores lower than the average of the general population were detected in 34 (74%) and 41 (89%) patients in the physical and mental domains, respectively. No difference between patients with and without Raynaud’s phenomenon was detected. Fibromyalgia was the only independent variable associated with an impaired physical component summary score ( p =?0.0009). No patient feature was found to be associated with the basal mental component summary score. During 24?months of follow-up, a significant improvement (ie, a change ≥5 from baseline) in physical component summary and mental component summary scores was observed in 14 (33.3%) and 20 (43.4%) patients, respectively. Patients who significantly improved in the physical domain more frequently had a history of glucocorticoids intake ( p
机译:简介/目的:前瞻性评估未分化结缔组织疾病(UCTDs)影响的患者的生活质量(QoL),并确定与时间变化相关的因素。患者和方法:共有46名连续UCTD患者在就诊时完成了简表36(SF-36)调查表,然后每年进行一次。在每个6个月的访视中,所有患者均接受详细的病史记录以及实验室和身体评估,以追踪疾病随时间的发展并评估纤维肌痛的共存。结果:在报告中,分别在身体和精神领域的34名(74%)和41名(89%)患者中检测到的分数低于一般人群的分数。没有发现有雷诺现象的患者之间没有差异。纤维肌痛是与受损的身体成分汇总评分相关的唯一独立变量(p =?0.0009)。未发现患者特征与基础心理成分摘要评分相关。在随访的24个月中,分别有14(33.3%)和20(43.4%)的患者观察到了身体成分摘要和精神成分摘要评分的显着改善(即,与基线相比变化≥5)。在物理方面有显着改善的患者更常有糖皮质激素的摄入史(p <0.001),而在精神方面有改善的患者更常有糖皮质激素(p =?0.043)或免疫抑制剂史(p = 0.037)随访期间的摄入量。结论:不管Raynaud的现象是什么,纤维肌痛是身体QoL的主要贡献者之一,UCTD患者的QoL都会变差,而没有发现影响心理成分的因素。在两年的随访中,不到一半的患者的QoL有所改善。需要更大的研究来确定影响QoL的因素并确定药理学治疗的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号